Mengxizhou Secures Tens of Millions in Series A Funding to Accelerate Internet Hospital Service Expansion

VCBeat (WeChat: vcbeat) has learned that Hangzhou Mengxizhou Network Technology Co., Ltd. (“Mengxizhou”) recently completed an RMB 10 million Series A financing round. The round was led by Pingyang Weilin Venture Capital Management Co., Ltd. (“Weilin VC”). The funds raised will be primarily used for the further development, promotion, and sales of Mengxizhou’s existing internet hospital service products.

Previously, Mengxizhou had completed a total of RMB 4 million in seed and angel round financing, with investors including Sycare Medical Information, a listed company in the healthcare sector, and Jianhai Technology, a unicorn enterprise in the digital therapeutics field.

It is understood that Mengxizhou, established in 2020, leverages its expertise in producing viral short-video content and managing internet traffic to provide content creation and traffic operation services for internet hospitals. By capitalizing on robust sales channels, the company creates new market opportunities in the B2B sector. Following this round of financing, Mengxizhou, driven by its innovative business model, will accelerate the expansion of its B2B market presence.

Su Tong, Co-founder and COO of Meng XizhouIntroduction: The company’s current business primarily focuses on the high-growth sector of internet hospital operations. Its core competency lies in addressing content, traffic, and operational challenges for internet hospitals, thereby unlocking the potential for revenue growth for hospitals and medical institutions. The company’s products rank among the industry leaders in both vertical specialization and production precision. Previously, the smart outpatient model jointly developed by Mengxizhou and the Nanfang Hospital Internet Hospital received the prestigious Industry Leading Award. Leveraging its high-quality service capabilities and robust sales channels, the company has achieved steady and rapid sales growth. Following this round of financing, the company will further accelerate the commercialization of its existing product lines while continuing to deepen its strategic layout in the field of single-disease digital therapeutics.

Meng Xizhou Co-Founder and CTO, Zhu Tianming“The internet hospital product and its supporting services represent a high-quality sector with broad prospects, and there is still significant room for growth in penetration and usage rates within the domestic market. Weilin Venture Capital, the new investor in Mengxizhou’s current funding round, is a venture capital firm with exceptionally strong post-investment resources. Many of its existing portfolio companies will empower Mengxizhou’s product lines through resource and technical support, providing substantial assistance to this startup. We believe that, with the support of both new and existing investors, Mengxizhou will achieve major breakthroughs in internet hospital services and single-disease digital therapeutics.”

Zhang Weiqiao, General Manager of Weilin Venture CapitalHe stated, “Meng Xizhou boasts a first-class team composed of top-tier talents from diverse fields, including media, major internet companies, government agencies, medical editing, and pharmaceutical marketing departments. The company’s supporting products for its internet hospital can deliver tangible value to both B-end clients and C-end patients. Furthermore, the company’s future roadmap includes highly competitive digital therapeutics products. Since its inception, Meng Xizhou has gained recognition from both the investment and industrial sectors, with Weilin Venture Capital expressing strong confidence in the company’s future growth.”

Weilin Venture Capital is an investment institution with extensive experience in capital operations, dedicated to providing comprehensive capital planning for enterprises at all stages of development. Weilin Venture Capital focuses on high-growth investment opportunities in new products, new technologies, and new markets, offering long-term support to foster corporate growth. It is also committed to in-depth industry research to identify high-quality companies with strong core technological and industry barriers. The firm has established a diversified portfolio across sectors including new energy, energy conservation and environmental protection, film and television culture, electronic information, cybersecurity, high-end equipment, and healthcare.